Dr. Andrew Whiteley
What this data tells you about Dr. Whiteley
Dr. Andrew Whiteley is an internal medicine specialist in Dallas, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Whiteley performed 53,269 Medicare services across 2,732 unique beneficiaries.
Between the years covered by Open Payments, Dr. Whiteley received a total of $1,665,815 from 57 pharmaceutical and/or device companies across 869 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Whiteley is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 10,710 | $0 | $5 |
| Anti-nausea injection (fosaprepitant) | 10,050 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 9,400 | $43 | $137 |
| Paclitaxel chemotherapy injection | 6,208 | $0 | $8 |
| Nivolumab injection (Opdivo) | 4,360 | $24 | $76 |
| Contrast dye for imaging (iodine-based) | 3,598 | $0 | $3 |
| Dexamethasone injection (steroid) | 1,399 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 830 | $1 | $114 |
| Blood draw (venipuncture) | 787 | $8 | $20 |
| Complete blood count (CBC) with differential | 726 | $8 | $36 |
| Office visit, established patient (30-39 min) | 698 | $92 | $368 |
| Injection, granisetron hydrochloride, 100 mcg | 560 | $0 | $24 |
| Comprehensive metabolic blood panel | 396 | $10 | $64 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 276 | $23 | $157 |
| Ferritin level test (iron stores) | 254 | $13 | $60 |
| Measurement of immunoglobulin light chains | 246 | $17 | $60 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 219 | $3 | $373 |
| Administration of chemotherapy into vein, 1 hour or less | 218 | $103 | $707 |
| Injection of additional new drug or substance into vein | 183 | $12 | $108 |
| Lactate dehydrogenase (enzyme) level | 182 | $6 | $31 |
| Injection, leucovorin calcium, per 50 mg | 182 | $3 | $25 |
| Injection, fluorouracil, 500 mg | 159 | $2 | $13 |
| Injection, carboplatin, 50 mg | 154 | $2 | $300 |
| Microscopic examination for white blood cells with manual cell count | 123 | $4 | $22 |
| Complete blood count (CBC), automated | 123 | $6 | $34 |
| Reticulated (young) platelet measurement | 115 | $34 | $143 |
| Injection, magnesium sulfate, per 500 mg | 102 | $1 | $6 |
| Injection, cisplatin, powder or solution, 10 mg | 91 | $2 | $94 |
| Hospital follow-up visit, moderate complexity | 70 | $62 | $247 |
| Administration of additional new drug or substance into vein, 1 hour or less | 66 | $52 | $344 |
| Injection, diphenhydramine hcl, up to 50 mg | 64 | $1 | $7 |
| Office visit, established patient (20-29 min) | 57 | $61 | $250 |
| Infusion, normal saline solution , 1000 cc | 53 | $2 | $19 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 48 | $48 | $313 |
| Administration of chemotherapy into vein, each additional hour | 46 | $23 | $161 |
| Injection, zoledronic acid, 1 mg | 46 | $7 | $431 |
| Unclassified drugs | 46 | $1 | $8 |
| Ct scan of chest with contrast | 34 | $53 | $821 |
| Drug injection, under skin or into muscle | 33 | $11 | $96 |
| Uric acid level test | 32 | $4 | $25 |
| CT scan of abdomen and pelvis with contrast | 31 | $183 | $1,067 |
| Complete x-ray of body bones | 31 | $55 | $207 |
| X-ray of upper arm, minimum of 2 views | 30 | $18 | $67 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 29 | $16 | $94 |
| New patient office visit, complex (60-74 min) | 22 | $170 | $709 |
| Office visit, established patient, complex (40-54 min) | 22 | $138 | $496 |
| Red blood count, automated test | 21 | $4 | $23 |
| Infusion into a vein for hydration, each additional hour | 20 | $10 | $75 |
| Basic metabolic blood panel | 19 | $8 | $49 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 19 | $91 | $657 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 17 | $16 | $100 |
| Administration of additional new drug or substance into vein using push technique | 16 | $44 | $289 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 14 | $135 | $500 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 12 | $132 | $523 |
| CT scan of chest, without contrast | 11 | $54 | $686 |
| New patient office visit (45-59 min) | 11 | $84 | $565 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (65%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Whiteley is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with speaking/promotional industry engagement in the top 0% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Whiteley experienced with iron infusion (feraheme)?
Does Dr. Whiteley receive payments from pharmaceutical companies?
How do Dr. Whiteley's costs compare to other internal medicine physicians in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology